Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis,Immunity, Inflammation and Disease

当前位置： X-MOL 学术 › Immun. Inflamm. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2020-10-20 , DOI: 10.1002/iid3.341
Dexi Zhou _{1,

2,

3} , Yilai Wu _{1,

2,

3} , Sheng Wang _{1,

2,

3} , Jun Li ₄ , Jiajie Luan _{1,

2,

3}

Affiliation

Organ fibrosis is a common pathological outcome of persistent tissue injury correlated with organ failure and death. Although current antifibrotic therapies have led to unprecedented successes, only a minority of patients with fibrosis benefit from these treatments. There is an urgent need to identify new targets and biomarkers that could be exploited in the diagnosis and treatment of fibrosis.

中文翻译：